Medicare Enrolled

Dr. Balesh Sharma, MD

Hematology & Oncology · Brownsville, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2150 N EXPRESSWAY, Brownsville, TX 78521
9565480810
In practice since 2006 (19 years)
NPI: 1578505483 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sharma

Dr. Balesh Sharma is a hematology & oncology in Brownsville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Sharma performed 18,765 Medicare services across 2,629 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sharma received a total of $7,461 from 50 pharmaceutical and/or device companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 33% volume in TX$ $7,461 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,765
Medicare services
Top 33% in TX for hematology & oncology
2,629
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~988 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)7,200$0$2
Epoetin alfa injection (Retacrit) for anemia2,950$6$28
Contrast dye for imaging (iodine-based)1,926$0$3
Complete blood count (CBC) with differential1,068$8$36
Office visit, established patient (30-39 min)940$87$368
Comprehensive metabolic blood panel861$10$64
Blood draw (venipuncture)785$8$20
Dexamethasone injection (steroid)354$0$1
Iron level test309$6$27
Iron binding capacity test309$9$35
Ferritin level test (iron stores)307$13$60
Drug injection, under skin or into muscle218$10$96
Lactate dehydrogenase (enzyme) level196$6$31
Reticulated (young) platelet measurement146$35$143
Administration of chemotherapy into vein, 1 hour or less140$93$707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less137$46$313
Office visit, established patient (20-29 min)118$62$250
Injection, zoledronic acid, 1 mg106$6$431
New patient office visit (45-59 min)80$117$565
Microscopic examination for white blood cells with manual cell count79$4$22
Complete blood count (CBC), automated79$6$34
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less65$20$157
Injection of additional new drug or substance into vein58$11$108
PSA test (prostate cancer screening)53$18$94
Administration of chemotherapy into vein, each additional hour53$21$161
Administration of additional new drug or substance into vein, 1 hour or less41$45$344
Nuclear medicine study from skull base to mid-thigh with ct scan37$1,082$4,802
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries34$90$657
Irrigation of implanted venous access drug delivery device28$16$114
Biopsy and aspiration of bone marrow sample for diagnosis19$129$523
Ct scan of chest with contrast16$47$821
CT scan of abdomen and pelvis with contrast15$175$1,067
Red blood count automated, with additional calculations14$5$26
Initial hospital admission, high complexity13$108$694
Basic metabolic blood panel11$8$49
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
69.8% medium
29.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,461
Total received (2018-2024)
Avg $1,066/year across 7 years
Top 36% in TX for hematology & oncology
50
Companies
175
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,183 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$279 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,552
2023
$2,004
2022
$1,287
2021
$151
2020
$225
2019
$1,074
2018
$1,168

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,014
AstraZeneca Pharmaceuticals LP
$833
Lilly USA, LLC
$478
Eisai Inc.
$417
Genentech USA, Inc.
$393
Janssen Biotech, Inc.
$337
Merck Sharp & Dohme LLC
$331
Amgen Inc.
$301
Taiho Oncology, Inc.
$198
Karyopharm Therapeutics Inc.
$171
Sumitomo Pharma America, Inc.
$169
Rigel Pharmaceuticals, Inc.
$146
GlaxoSmithKline, LLC.
$143
Celgene Corporation
$128
Astellas Pharma US Inc
$128
Tempus AI, Inc
$127
PFIZER INC.
$114
Novartis Pharmaceuticals Corporation
$114
EISAI INC.
$111
BeiGene USA, Inc.
$111
Merck Sharp & Dohme Corporation
$106
Daiichi Sankyo Inc.
$105
Exelixis Inc.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$102
Jazz Pharmaceuticals Inc.
$102
Janssen Scientific Affairs, LLC
$90
Helsinn Therapeutics (U.S.), Inc.
$86
Sobi, Inc
$85
Blueprint Medicines Corporation
$85
ADC Therapeutics America, Inc.
$82
GENZYME CORPORATION
$80
Regeneron Healthcare Solutions, Inc.
$79
Seagen Inc.
$72
Mirati Therapeutics, Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$59
Gilead Sciences, Inc.
$57
TAIHO ONCOLOGY, INC.
$35
Bayer HealthCare Pharmaceuticals Inc.
$33
ARRAY BIOPHARMA INC
$31
Apellis Pharmaceuticals, Inc.
$30
SOBI, INC
$30
Myovant Sciences Inc.
$29
Adaptive Biotechnologies Corporation
$25
JAZZ PHARMACEUTICALS INC.
$23
Janssen Pharmaceuticals, Inc
$22
Puma Biotechnology, Inc.
$18
Stemline Therapeutics Inc.
$18
Ipsen Biopharmaceuticals, Inc
$17
Ferring Pharmaceuticals Inc.
$16
Acrotech Biopharma LLC
$12
Top 3 companies account for 31.2% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ALUNBRIG · AYVAKIT · Avastin · BELEODAQ · BRUKINSA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ENJAYMO · ERLEADA · Empaveli · Enhertu · Erleada · FRUZAQLA · Fabhalta · GAZYVA · Halaven · IBRANCE · IMFINZI · INLYTA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · NERLYNX · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · Perjeta · Pomalyst · Prolia · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · Stivarga · TAGRISSO · TECVAYLI · TIVDAK · TRUSELTIQ · Tavalisse · Tecentriq · Trodelvy · VERZENIO · VPRIV · VYXEOS · XALKORI · XPOVIO · XT CDX · Xtandi · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $40 per 100 Medicare services performed
Looking for a hematology & oncology in Brownsville?
Compare hematology & oncologys in the Brownsville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
2
Per 100K population
0.5
County median income
$51,334
Nearest hospital
VALLEY REGIONAL MEDICAL CENTER
9.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sharma is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sharma experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Sharma performed 7,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $7,461 from 50 companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other hematology & oncologys in Brownsville?
Dr. Sharma's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →